DCT

3:17-cv-11510

Boehringer Ingelheim Pharma Inc v. Teva Pharma USA Inc

General

Filed

11/10/17

Cause of ActionInfringement

SectorBiotech

Status

Closed (07/02/20)

Patent Owner

NPE (W)

SourcePACER

CourtD. New Jersey

Judge	Period	PO Win Rate
Michael A. Shipp	11/14/17 - 07/23/20	60%

MagistrateLois H. Goodman

Plaintiff

Party

Name	Ratings
Boehringer-Ingelheim Pharma GMBH NPE	L4A
Boehringer Ingelheim Pharmaceuticals Inc NPE	L4A
Boehringer Ingelheim Intl GmbH	L4A

Attorney

Name	Ratings
Covington & Burling LLP	L4B
Jeffrey H. Lerner	L5A
Christopher N. Sipes	L5C
Jeremy D. Cobb	L4C
Alexander Trzeciak	L3A
Daniel W. Cho	L1C
Saul Ewing LLP	L3B
William C. Baton	L5A
Charles M. Lizza	L5A
Sarah Ann Sullivan	L4A
David L. Moses	L2A

Defendant

Party

Name	Ratings
Teva Pharmaceuticals USA Inc	L5E
Teva Pharmaceutical Industries Ltd	L5E
Actavis LLC	L5E

Attorney

Name	Ratings
Winston Taylor LLP	L5B
Samuel S. Park	L5D
Melissa S. Bogad	L5E